We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Get the Latest Clinical Insights for Tumor Exome Profiling

Get the Latest Clinical Insights for Tumor Exome Profiling
Credit : iStock

Whole-exome sequencing (WES) has been increasingly adopted into oncology testing and research to profile tumor samples. It can be used to guide treatment selection, identify emerging biomarkers and predict patient responses to immune checkpoint inhibitors.

Exome enrichment supports deeper coverage, cost effectiveness and improved variant calling. However, the complexity of sequencing data can present challenges for the analysis and interpretation of relevant clinical insights.

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights. 

Download this whitepaper to discover: 

  • High-performance workflows for somatic mutation detection and SNP variant calling 
  • Genomic data reporting, interpretation and quality control solutions
  • An expertly curated internal knowledge base full of up-to-date clinical findings

Access This Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.